Efficacy and Safety of Biosimilar QL1207 vs. the Reference Aflibercept for Patients with Neovascular Age-Related Macular Degeneration: A Randomized Phase 3 Trial

被引：0

作者：

Bing Li

Ke Fan

Tonghe Zhang

Zhifeng Wu

Siming Zeng

Mingwei Zhao

Qian Ren

Dongping Zheng

Lifei Wang

Xiaoling Liu

Mei Han

Yanping Song

Jian Ye

Cheng Pei

Jinglin Yi

Xian Wang

Hui Peng

Hong Zhang

Zhanyu Zhou

Xiaoling Liang

Fangliang Yu

Miaoqin Wu

Chaopeng Li

Chunling Lei

Jilong Hao

Luosheng Tang

Huiping Yuan

Shanjun Cai

Qiuming Li

Jingxiang Zhong

Suyan Li

Lin Liu

Min Ke

Jing Wang

Hui Wang

Mengli Zhu

Zenghua Wang

Yang Yan

Feng Wang

Youxin Chen

机构：

[1] Peking Union Medical College Hospital,Ophthalmology Department

[2] Henan Provincial Eye Hospital,Ophthalmology Department

[3] Jinan Second People’s Hospital,Ophthalmology Department

[4] Wuxi Second People’s Hospital,Ophthalmology Department

[5] Guangxi Zhuang Autonomous Region People’s Hospital,Ophthalmology Department

[6] Peking University People’s Hospital,Ophthalmology Department

[7] Shijiazhuang People’s Hospital,Ophthalmology Department

[8] Shanxi Ophthalmic Hospital,Ophthalmology Department

[9] Hebei Eye Hospital,Ophthalmology Department

[10] Eye Hospital,Ophthalmology Department

[11] WMU Zhejiang Eye Hospital,Ophthalmology Department

[12] Tianjin Eye Hospital,Ophthalmology Department

[13] General Hospital of Central Theater Command,Ophthalmology Department

[14] Army Medical Center of PLA,Ophthalmology Department

[15] The First Affiliated Hospital of Xi’an Jiaotong University,Ophthalmology Department

[16] Affiliated Eye Hospital of Nanchang University,Ophthalmology Department

[17] The Affiliated Hospital of Guizhou Medical University,Ophthalmology Department

[18] The First Affiliated Hospital of Chongqing Medical University,Ophthalmology Department

[19] The First Affiliated Hospital of Harbin Medical University,Ophthalmology Department

[20] Qingdao Municipal Hospital,Ophthalmology Department

[21] Zhongshan Ophthalmic Center,Ophthalmology Department

[22] Sun Yat-Sen University,Ophthalmology Department

[23] The First Hospital of Nanchang,Ophthalmology Department

[24] Zhejiang Provincial People’s Hospital,Ophthalmology Department

[25] Huai’an First People’s Hospital,Ophthalmology Department

[26] Xi’an People’s Hospital,Ophthalmology Department

[27] First Hospital of Jilin University,Ophthalmology Department

[28] The Second Xiangya Hospital of Center South University,Ophthalmology Department

[29] The Second Affiliated Hospital of Harbin Medical University,Ophthalmology Department

[30] Affiliated Hospital of Zunyi Medical University,Ophthalmology Department

[31] The First Affiliated Hospital of Zhengzhou University,Ophthalmology Department

[32] The First Affiliated Hospital of Jinan University,Ophthalmology Department

[33] Xuzhou First People’s Hospital,Ophthalmology Department

[34] Renji Hospital Affiliated to Shanghai Jiaotong University,Clinical Research Center

[35] Wuhan University Zhongnan Hospital,Ophthalmology Department

[36] Qilu Pharmaceutical Co.,undefined

[37] Ltd.,undefined

[38] The Second Affiliated Hospital of Xi’an Jiaotong University,undefined

来源：

Ophthalmology and Therapy | 2024年 / 13卷

关键词：

Neovascular age-related macular degeneration; QL1207; Aflibercept; Biosimilar;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：353 / 366

页数：13

共 50 条

[21] Efficacy, Safety and Immunogenicity of Sun’s Ranibizumab Biosimilar in Neovascular Age-Related Macular Degeneration: A Phase 3, Double-Blind Comparative Study
Asim K. Ghosh
Usha S. Nikumbh
Chaitanya K. Shukla
Rohit S. Laul
Abhishek Dixit
Santosh K. Mahapatra
Sameera Nayak
Urmil M. Shah
Sandeep Parwal
Narendran Venkatapathy
Natasha Radhakrishnan
Anup Kelgaonkar
Sandeep Saxena
Divyansh Mishra
Vivek Pravin Dave
Perwez Khan
Manojkumar R. Saswade
Malli S. Shantilal
Kim Ramasamy
Smitha Sreekanta
Mandodari Rajurkar
Maulik Doshi
Sapan Behera
Piyush Patel
Shilpi Dhawan
Lalit Lakhwani
Ophthalmology and Therapy, 2024, 13 : 1369 - 1382
[22] Efficacy and Safety of Abicipar in Neovascular Age-Related Macular Degeneration 52-Week Results of Phase 3 Randomized Controlled Study
Kunimoto, Derek
Yoon, Young Hee
Wykoff, Charles C.
Chang, Andrew
Khurana, Rahul N.
Maturi, Raj K.
Agostini, Hansjuergen
Souied, Eric
Chow, David R.
Lotery, Andrew J.
Ohji, Masahito
Bandello, Francesco
Belfort, Rubens, Jr.
Li, Xiao-Yan
Jiao, Jenny
Le, Grace
Schmidt, Werner
Hashad, Yehia
OPHTHALMOLOGY, 2020, 127 (10) : 1331 - 1344
[23] EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT AND RANIBIZUMAB IN ASIAN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Subgroup Analyses From the VIEW Trials
Wong, Tien Yin
Cheung, Chui Ming Gemmy
Lai, Timothy Y. Y.
Chen, Shih-Jen
Lee, Won Ki
Yoon, Young Hee
Iida, Tomohiro
Tueckmantel, Claudia
Sowade, Olaf
Ogura, Yuichiro
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2019, 39 (03): : 537 - 547
[24] Efficacy and Safety of Efdamrofusp Alfa versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration A Randomized, Double-Masked, Active-Controlled, Noninferiority, Phase II Trial
Sun, Junran
Song, Yanping
Gong, Yuanyuan
Tao, Liming
Wang, Hong
Shu, Xiangwen
Wen, Ying
Cui, Ling
Ye, Jian
Lu, Shujie
Deng, Junjie
Li, Haoyu
Xu, Yihua
Qian, Lei
Wu, Zhifeng
Bi, Yanlong
Liu, Qinghuai
Xu, Xiangzhong
Wu, Miaoqin
Zhang, Jinglin
Hao, Jilong
Tong, Jianping
Dai, Hong
Wang, Feng
Zhao, Mingwei
Mao, Junfeng
Li, Chaopeng
He, Tao
Pei, Cheng
Liu, Xiaoling
Wang, Xian
Li, Mingxin
Wang, Wei
Zheng, Qinxiang
Guan, Huaijin
Peng, Hui
Fan, Ke
Zhang, Wenfang
Zhu, Dan
Yu, Songping
Wei, Wenbin
Ding, Lin
Li, Jinying
Lu, Peirong
Yan, Ming
Liu, Wei
Jia, Huixun
Sun, Xiaodong
OPHTHALMOLOGY RETINA, 2025, 9 (02): : 156 - 165
[25] INTRAVITREAL AFLIBERCEPT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH LIMITED RESPONSE TO RANIBIZUMAB A Treat-and-Extend Trial
Hatz, Katja
Prunte, Christian
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (06): : 1185 - 1192
[26] A Randomized, Controlled Trial of Treat-and-Extend vs. Pro Re Nata Regimen for Neovascular Age-Related Macular Degeneration
Jia, Huixun
Lu, Bing
Yuan, Yuanzhi
Yuan, Fei
Li, Lei
Song, Yanping
Rong, Ao
Zhou, Minwen
Wang, Fenghua
Sun, Xiaodong
FRONTIERS IN MEDICINE, 2022, 9
[27] Effect of intravitreal aflibercept (Eylea®) on retrobulbar hemodynamics in patients with neovascular age-related macular degeneration
Mustafa Gok
Hasan Burhanettin Kapti
International Ophthalmology, 2018, 38 : 713 - 719
[28] HAWK Extension Study: Safety and Efficacy of Intravitreal Brolucizumab in Neovascular Age-related Macular Degeneration
Brown, David M.
Nowik, Marta
Bouillaud, Emmanuel
Dugel, and Pravin U.
CURRENT EYE RESEARCH, 2023, 48 (01) : 44 - 50
[29] Efficacy of intravitreal aflibercept in Japanese patients with exudative age-related macular degeneration
Masaaki Saito
Mariko Kano
Kanako Itagaki
Tetsuju Sekiryu
Japanese Journal of Ophthalmology, 2017, 61 : 74 - 83
[30] Efficacy of intravitreal aflibercept in Japanese patients with exudative age-related macular degeneration
Saito, Masaaki
Kano, Mariko
Itagaki, Kanako
Sekiryu, Tetsuju
JAPANESE JOURNAL OF OPHTHALMOLOGY, 2017, 61 (01) : 74 - 83

← 1 2 3 4 5 →